Full Coverage

FDA wary of deaths with Pfizer osteoporosis drug

                   
pharmiweb.co.uk
04-Sep-2008
        
Story Timeline:  91 days

Thursday September 4, 11:42 am ET By Matthew Perrone, AP Business Writer FDA has concerns about death, blood clots with Pfizer and Ligand osteoporosis drug WASHINGTON (AP) -- Federal regulators say a drug from Pfizer and Ligand Pharmaceuticals effectively treats osteoporosis, though they are concerned about deaths, blood clots and other problems seen in company studies. The Food and Drug Administration noted... [read full story]                    

Add Comment
Latest article on this story:

FDA cites risks of Pfizer bone drug

 pharmiweb.co.uk 05-Sep-2008
First article on this story:

FDA staff note deaths in Pfizer bone drug study (Reuters)

 yahoo.com 04-Sep-2008
Selected publications with coverage of this story:
forbes.com canadianbusiness.com yahoo.com newyorkbusiness.com pharmiweb.co.uk
RELATED
Found 6 documents:

FDA cites risks of Pfizer bone drug

pharmiweb.co.uk
05-Sep-2008
        

The Star-Ledger - Sep. 05, 2008 Pfizer's experimental treatment for women with weak bones may increase the risk of death, blood clots or gynecological side effects, federal regulators said. The risks of the once-a-day...

                   

FDA concerned with deaths linked to Pfizer?s bone drug

pharmiweb.co.uk
05-Sep-2008
        

Pfizer’s shares dropped more than 2% yesterday after US regulators cited concerns over the drug giant’s osteoporosis drug Fablyn (lasofoxifene). New research has shown women who took the drug had a higher incidence of...

                   

FDA staff note deaths in Pfizer bone drug study

pharmiweb.co.uk
04-Sep-2008
        

By Lisa Richwine WASHINGTON (Reuters) - Osteoporosis patients who received a low dose of an experimental Pfizer Inc pill were more likely to die within five years than others who got a placebo, U.S. drug reviewers said...

                   

FDA has concerns about death, blood clots with Pfizer and Ligand osteoporosis drug

canadianbusiness.com
04-Sep-2008
        

WASHINGTON (AP) - Federal regulators say a drug from Pfizer and Ligand Pharmaceuticals effectively treats osteoporosis, though they are concerned about deaths, blood clots and other problems seen in company studies. The...

                   

FDA has concerns about death, blood clots with Pfizer and Ligand osteoporosis drug

pharmiweb.co.uk
04-Sep-2008
        

WASHINGTON (AP) - Federal regulators say a drug from Pfizer and Ligand Pharmaceuticals effectively treats osteoporosis, though they are concerned about deaths, blood clots and other problems seen in company studies. The...

FDA Says Proposed Pfizer Drug Reduced Risk Of Spine Fracture (DJ)

pharmiweb.co.uk
04-Sep-2008
        

By Jared A. Favole Of DOW JONES NEWSWIRES WASHINGTON -(Dow Jones)- Clinical trials of Pfizer Inc.'s (PFE) new proposed drug to treat osteoporosis in postmenopausal women showed a lower risk that patients would develop...